You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Atenolol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for atenolol and what is the scope of freedom to operate?

Atenolol is the generic ingredient in five branded drugs marketed by Astrazeneca, Able, Apothecon, Aurobindo Pharma, Chartwell Rx, Hlthcare, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, SCS, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Twi Pharms, Unichem, Unique, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, Aurobindo Pharma Usa, Novitium Pharma, and Zydus Pharms, and is included in forty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for atenolol. Thirty-three suppliers are listed for this compound.

Drug Prices for atenolol

See drug prices for atenolol

Drug Sales Revenue Trends for atenolol

See drug sales revenues for atenolol

Recent Clinical Trials for atenolol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Zagazig UniversityPhase 2
Ain Shams UniversityPhase 4
University of California, San FranciscoPhase 3

See all atenolol clinical trials

Pharmacology for atenolol

US Patents and Regulatory Information for atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Twi Pharms ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 072302-002 May 31, 1990 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hlthcare ATENOLOL atenolol TABLET;ORAL 073026-003 Sep 17, 1991 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ipca Labs Ltd ATENOLOL atenolol TABLET;ORAL 077877-001 Dec 27, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Scs ATENOLOL atenolol TABLET;ORAL 073676-001 Oct 30, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Strides Pharma ATENOLOL atenolol TABLET;ORAL 073543-001 Dec 19, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for atenolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Twi Pharms TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORMIN atenolol TABLET;ORAL 018240-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.